Source: Annual Congress 2002 - Pulmonary imaging
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. K. Coker, P. W. Ind, J. M. B. Hughes, M. Myers, A. Al-Nahhas, J. W. Frank (London, United Kingdom). Functional imaging of disease activity in sarcoidosis. Eur Respir J 2002; 20: Suppl. 38, 1705

Member's Comments

No comment yet.

Related content which might interest you: Value of MR imaging in the early detection of cardiac involvement in sarcoidosis Source: Annual Congress 2006 - New modalities and application in imaging of the chest Year: 2006 Assessment of disease severity using imaging scores in pulmonary sarcoidosis Source: Annual Congress 2012 - Diffuse parenchymal lung disease II Year: 2012 Long-term results obtained by cardiovascular magnetic resonance imaging and somatostatin receptor PET in cardiac sarcoidosis Source: International Congress 2016 – Mixed-up imaging of various chest diseases Year: 2016 Thoracic involvement and imaging patterns in IgG4-related disease Source: Eur Respir Rev, 30 (162) 210078; 10.1183/16000617.0078-2021 Year: 2021 MR imaging of lung parenchymal changes in sarcoidosis Source: International Congress 2016 – Mixed-up imaging of various chest diseases Year: 2016 Early alterations of lung parenchyma in acromegaly Source: International Congress 2014 – Pathophysiological mechanisms at different scales Year: 2014 Evaluation of pleural disease with FDG-PET imaging Source: Annual Congress 2003 - Early lung cancer diagnosis Year: 2003 Evaluation of lung high-resolution computed tomography changes in patients with Churg-Strauss syndrome as related to the activity of the disease Source: Annual Congress 2010 - Biomarkers and Diagnosis of asthma and allergic respiratory diseases Year: 2010 The utility of 18F-FDG PET/CT in chronic sarcoidosis Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013 The Value of 18F-FDG PET/CT in evaluating disease severity in idiopathic pulmonary fibrosis Source: International Congress 2017 – ILDs: clinical aspects Year: 2017 Novel magnetic resonance technique for functional imaging of cystic fibrosis lung disease Source: Eur Respir J, 50 (6) 1701464; 10.1183/13993003.01464-2017 Year: 2017 The utility of cardiac magnetic resonance imaging in the diagnosis of cardiac sarcoidosis Source: International Congress 2014 – The MRI modality becomes clinically mature: lung MRI Year: 2014 The 18F PET/CT scan in patients with chronic sarcoidosis Source: International Congress 2016 – Sarcoidosis Year: 2016 Evaluation of cardiac functions by tissue doppler imaging in patients with systemic sarcoidosis Source: Eur Respir J 2004; 24: Suppl. 48, 713s Year: 2004 Understanding the relationship between percentage emphysema as assessed by volumetric CT and lung function in patients with chronic obstructive pulmonary disease Source: International Congress 2014 – Multidimensional analysis of respiratory problems Year: 2014 Oxygen-enhanced MRI of the lung in the assessment of chronic obstructive pulmonary disease Source: Annual Congress 2006 - New modalities and application in imaging of the chest Year: 2006 Longitudinal high-resolution computed tomography (HRCT) assessment and disease progression in patients with Idiopathic Pulmonary Fibrosis (IPF) on antifibrotic therapy Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis Year: 2019 99mTc-anti-TNF-alpha antibody for the imaging of disease activity in pulmonary sarcoidosis Source: Eur Respir J 2016; 47: 1198-1207 Year: 2016 Diagnosis of sarcoidosis activity Source: Eur Respir J 2004; 24: Suppl. 48, 713s Year: 2004 Use of MRI for functional and structural assessment of interstitial lung disease Source: International Congress 2018 – Emerging and novel imaging biomarkers in drug-induced interstitial lung disease Year: 2018